132 related articles for article (PubMed ID: 15316019)
1. Crystal structure of ADP-ribosylated ribosomal translocase from Saccharomyces cerevisiae.
Jørgensen R; Yates SP; Teal DJ; Nilsson J; Prentice GA; Merrill AR; Andersen GR
J Biol Chem; 2004 Oct; 279(44):45919-25. PubMed ID: 15316019
[TBL] [Abstract][Full Text] [Related]
2. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
Nygård O; Nilsson L
Biochim Biophys Acta; 1985 Feb; 824(2):152-62. PubMed ID: 3970930
[TBL] [Abstract][Full Text] [Related]
3. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry.
Jørgensen R; Merrill AR; Yates SP; Marquez VE; Schwan AL; Boesen T; Andersen GR
Nature; 2005 Aug; 436(7053):979-84. PubMed ID: 16107839
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide binding to elongation factor 2 inactivated by diphtheria toxin.
Burns G; Abraham AK; Vedeler A
FEBS Lett; 1986 Nov; 208(2):217-20. PubMed ID: 3780964
[TBL] [Abstract][Full Text] [Related]
5. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
Parikh SL; Schramm VL
Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
[TBL] [Abstract][Full Text] [Related]
6. Expression of non-ADP-ribosylatable, diphtheria toxin-resistant elongation factor 2 in Saccharomyces cerevisiae.
Kimata Y; Harashima S; Kohno K
Biochem Biophys Res Commun; 1993 Mar; 191(3):1145-51. PubMed ID: 8466491
[TBL] [Abstract][Full Text] [Related]
7. The role of the diphthamide-containing loop within eukaryotic elongation factor 2 in ADP-ribosylation by Pseudomonas aeruginosa exotoxin A.
Zhang Y; Liu S; Lajoie G; Merrill AR
Biochem J; 2008 Jul; 413(1):163-74. PubMed ID: 18373493
[TBL] [Abstract][Full Text] [Related]
8. ADP-ribosylated elongation factor 2 (ADP-ribosyl-EF-2) is unable to promote translocation within the ribosome.
Davydova EK; Ovchinnikov LP
FEBS Lett; 1990 Feb; 261(2):350-2. PubMed ID: 2311763
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
Fendrick JL; Iglewski WJ; Moehring JM; Moehring TJ
Eur J Biochem; 1992 Apr; 205(1):25-31. PubMed ID: 1313365
[TBL] [Abstract][Full Text] [Related]
10. Effect of ADP-ribosylation and phosphorylation on the interaction of elongation factor 2 with guanylic nucleotides.
Marzouki A; Sontag B; Lavergne JP; Vidonne C; Reboud JP; Reboud AM
Biochimie; 1991; 73(7-8):1151-6. PubMed ID: 1742357
[TBL] [Abstract][Full Text] [Related]
11. Two crystal structures demonstrate large conformational changes in the eukaryotic ribosomal translocase.
Jørgensen R; Ortiz PA; Carr-Schmid A; Nissen P; Kinzy TG; Andersen GR
Nat Struct Biol; 2003 May; 10(5):379-85. PubMed ID: 12692531
[TBL] [Abstract][Full Text] [Related]
12. Domain movements of elongation factor eEF2 and the eukaryotic 80S ribosome facilitate tRNA translocation.
Spahn CM; Gomez-Lorenzo MG; Grassucci RA; Jørgensen R; Andersen GR; Beckmann R; Penczek PA; Ballesta JP; Frank J
EMBO J; 2004 Mar; 23(5):1008-19. PubMed ID: 14976550
[TBL] [Abstract][Full Text] [Related]
13. Diphtheria toxin. Site and configuration of ADP-ribosylation of diphthamide in elongation factor 2.
Oppenheimer NJ; Bodley JW
J Biol Chem; 1981 Aug; 256(16):8579-81. PubMed ID: 6267047
[TBL] [Abstract][Full Text] [Related]
14. Modes of action of ADP-ribosylated elongation factor 2 in inhibiting the polypeptide elongation cycle: a modeling study.
Chen KC; Xie H; Cai Y
PLoS One; 2013; 8(7):e66446. PubMed ID: 23861744
[TBL] [Abstract][Full Text] [Related]
15. Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment.
Ergen K; Bektaş M; Gökçe S; Nurten R
Biocell; 2007; 31(1):61-6. PubMed ID: 17665640
[TBL] [Abstract][Full Text] [Related]
16. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
Bektaş M; Nurten R; Ergen K; Bermek E
Cell Biochem Funct; 2006; 24(4):369-80. PubMed ID: 16142694
[TBL] [Abstract][Full Text] [Related]
17. Structural Insights into
Gholami A; Minai-Tehrani D; Mahdizadeh SJ; Saenz-Mendez P; Eriksson LA
J Chem Inf Model; 2023 Mar; 63(5):1578-1591. PubMed ID: 36802593
[TBL] [Abstract][Full Text] [Related]
18. Translation elongation factor 2 anticodon mimicry domain mutants affect fidelity and diphtheria toxin resistance.
Ortiz PA; Ulloque R; Kihara GK; Zheng H; Kinzy TG
J Biol Chem; 2006 Oct; 281(43):32639-48. PubMed ID: 16950777
[TBL] [Abstract][Full Text] [Related]
19. Kinetic determination of the effects of ADP-ribosylation on the interaction of eukaryotic elongation factor 2 with ribosomes.
Nygård O; Nilsson L
J Biol Chem; 1990 Apr; 265(11):6030-4. PubMed ID: 2318846
[TBL] [Abstract][Full Text] [Related]
20. Highly frequent single amino acid substitution in mammalian elongation factor 2 (EF-2) results in expression of resistance to EF-2-ADP-ribosylating toxins.
Kohno K; Uchida T
J Biol Chem; 1987 Sep; 262(25):12298-305. PubMed ID: 2887567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
